Tianeptine antagonizes the reduction of PV+ and GAD67 cells number in dorsal hippocampus of socially isolated rats

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8:89:386-399. doi: 10.1016/j.pnpbp.2018.10.013. Epub 2018 Oct 25.

Abstract

Adult male rats exposed to chronic social isolation (CSIS) show depressive- and anxiety-like behaviors and reduce the numbers of parvalbumin-positive (PV+) interneurons in the dorsal hippocampus. We aimed to determine whether tianeptine (Tian), administered during the last three weeks of a six-week-social isolation (10 mg/kg/day), may reverse CSIS-induced behavioral changes and antagonize the CSIS-induced reduction in the number of PV+ interneurons. We also studied whether Tian affects the GABA-producing enzyme GAD67+ cells, in Stratum Oriens (SO), Stratum Pyramidale (SP), Stratum Radiatum (SR) and Stratum Lacunosum Moleculare (LM) of CA1-3, as well as in molecular layer-granule cell layer (ML-GCL) and Hilus (H) of the dentate gyrus (DG). CSIS-induced reduction in the number of PV+ cells was layer/subregion-specific with the greatest decrease in SO of CA2. Reduction in the number of PV+ cells was significantly higher than GAD67+ cells, indicating that PV+ cells are the main target following CSIS. Tian reversed CSIS-induced behavior phenotype and antagonized the reduction in the number of PV+ and GAD67+ cells in all subregions. In controls, Tian led to an increase in the number of PV+ and GAD67+ cells in SP of all subregions and PV+ interneurons in ML-GCL of DG, while treatment during CSIS, compared to CSIS alone, resulted with an increase of PV+ interneurons in SO and SP CA1, SP CA2/CA3 and ML-GCL DG with simultaneous increase in GAD67+ cells in all CA1, LM CA2, SO/SR/LM CA3. Data show that Tian offers protection from CSIS via modulation of the dorsal hippocampal GABAergic system.

Keywords: Depression; Dorsal hippocampus; GAD67; Parvalbumin; Tianeptine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Antidepressive Agents, Tricyclic / pharmacology*
  • Anxiety / drug therapy
  • Anxiety / etiology
  • Anxiety / metabolism
  • Anxiety / pathology
  • Cell Count
  • Depression / drug therapy
  • Depression / etiology
  • Depression / metabolism
  • Depression / pathology
  • Glutamate Decarboxylase / metabolism
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Male
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / pathology
  • Parvalbumins / metabolism
  • Random Allocation
  • Rats, Wistar
  • Social Isolation* / psychology
  • Thiazepines / pharmacology*

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents, Tricyclic
  • Parvalbumins
  • Thiazepines
  • tianeptine
  • Glutamate Decarboxylase
  • glutamate decarboxylase 1